Banco Bilbao V/Argntna SA (BBVXF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BBVXF SEC filings page.
Banco Bilbao V/Argntna SA (BBVXF) reported $43.3B in revenue for fiscal year 2025, up 18.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
Financial Health Signals
We do not publish a peer-relative financial health score for Banco Bilbao V/Argntna SA, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Banco Bilbao V/Argntna SA passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
Banco Bilbao V/Argntna SA earns $0.50 in operating income for every $1 of interest expense ($19.0B vs $37.6B). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Banco Bilbao V/Argntna SA generated $43.3B in revenue in fiscal year 2025. This represents an increase of 18.0% from the prior year.
Banco Bilbao V/Argntna SA's EBITDA was $20.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.7% from the prior year.
Banco Bilbao V/Argntna SA reported $12.3B in net income in fiscal year 2025. This represents an increase of 18.5% from the prior year.
Banco Bilbao V/Argntna SA earned $2.07 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.8% from the prior year.
Cash & Balance Sheet
Banco Bilbao V/Argntna SA generated $16.6B in free cash flow in fiscal year 2025, representing cash available after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
Banco Bilbao V/Argntna SA held $69.1B in cash as of fiscal year 2025; no long-term debt figure is on record for that period.
Not reported for fiscal year 2025.
Margins & Returns
Banco Bilbao V/Argntna SA's operating margin was 43.7% in fiscal year 2025, reflecting core business profitability. This is up 0.5 percentage points from the prior year.
Banco Bilbao V/Argntna SA's net profit margin was 28.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.
Banco Bilbao V/Argntna SA's ROE was 17.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Banco Bilbao V/Argntna SA spent $2.3B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 48.0% from the prior year.
Banco Bilbao V/Argntna SA invested $970.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 21.5% from the prior year.
Not reported for fiscal year 2025.
BBVXF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43.3B+18.0% | $36.7B+12.4% | $32.7B+23.5% | $26.5B+11.0% | $23.8B-3.3% | $24.7B+2.1% | $24.2B+0.7% | $24.0B-21.1% | $30.4B+16.8% | $26.0B+2.5% | $25.4B |
| Gross Profit | N/A | N/A | N/A | N/A | $23.8B-3.3% | $24.7B+2.1% | $24.2B+0.7% | $24.0B-21.1% | $30.4B+16.8% | $26.0B+2.5% | $25.4B |
| Operating Income | $19.0B+19.4% | $15.9B+15.5% | $13.8B+23.9% | $11.1B+31.0% | $8.5B+34.4% | $6.3B-22.1% | $8.1B+3.7% | $7.8B-10.2% | $8.7B+19.7% | $7.3B+6.9% | $6.8B |
| EBITDA | $20.7B+18.7% | $17.5B+14.2% | $15.3B+22.3% | $12.5B+26.9% | $9.9B+25.3% | $7.9B-18.3% | $9.6B+7.3% | $9.0B-13.2% | $10.3B+18.2% | $8.8B+7.2% | $8.2B |
| Interest Expense | $37.6B-0.1% | $37.7B+37.5% | $27.4B+108.0% | $13.2B+39.7% | $9.4B-1.1% | $9.5B-29.1% | $13.4Bn/m | -$13.4Bn/m | -$13.9Bn/m | -$11.2B-218.1% | $9.5B |
| Income Tax | $6.0B+19.7% | $5.0B+12.9% | $4.4B+18.1% | $3.7B+73.5% | $2.2B+21.1% | $1.8B-18.2% | $2.2Bn/m | -$2.3Bn/m | -$2.6Bn/m | -$1.8Bn/m | -$1.4B |
| Net Income | $12.3B+18.5% | $10.4B+17.3% | $8.9B+30.4% | $6.8B+29.2% | $5.3B+230.0% | $1.6B-59.5% | $3.9B-36.3% | $6.2B+46.4% | $4.2B+15.2% | $3.7B+27.8% | $2.9B |
| EPS (Basic) | $2.07+18.8% | $1.74+21.9% | $1.43+36.1% | $1.05+38.3% | $0.76 | $0.17 | $0.53-38.6% | $0.86 | $0.55+7.0% | $0.52+28.7% | $0.40 |
| EPS (Diluted) | $2.07+18.8% | $1.74+21.9% | $1.43+36.1% | $1.05+47.0% | $0.71 | $0.49 | $0.65-11.2% | $0.73 | $0.55+7.0% | $0.52+28.7% | $0.40 |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | N/A | 6,655 | 6,648+0.2% | 6,636 | 6.64B+0.8% | 6.59B-0.8% | 6.65B |
Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, SG&A Expenses.
BBVXF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.0T+26.2% | $799.5B-6.8% | $857.9B+12.6% | $761.8B+1.5% | $750.3B-16.4% | $897.4B+14.9% | $780.8B+0.9% | $774.1B-6.7% | $829.6B+7.4% | $772.3B-5.2% | $814.3B |
| Cash & Equivalents | $69.1B+30.4% | $52.9B-36.5% | $83.4B-2.2% | $85.3B+11.2% | $76.7B-18.4% | $94.0B+89.1% | $49.7B-25.4% | $66.7B+29.9% | $51.3B+21.4% | $42.2B+32.9% | $31.8B |
| Inventory | N/A | N/A | N/A | N/A | N/A | $699.6M+7.2% | $652.3M-10.3% | $727.5M+164.2% | $275.3M-92.1% | $3.5B-25.5% | $4.7B |
| Goodwill | $839.1M+15.8% | $724.6M-17.6% | $879.4M+16.3% | $756.3M-18.3% | $925.8M-16.8% | $1.1B-80.0% | $5.6B-21.4% | $7.1B-2.9% | $7.3B-0.4% | $7.3B-2.5% | $7.5B |
| Total Liabilities | $936.3B+27.0% | $737.4B-7.5% | $796.8B+12.6% | $707.8B+1.8% | $695.1B-16.9% | $836.3B+16.3% | $719.1B+0.8% | $713.5B-6.8% | $765.5B+7.2% | $713.8B-5.4% | $754.2B |
| Total Equity | $72.5B+16.8% | $62.1B+1.6% | $61.1B+13.1% | $54.0B-2.0% | $55.2B-9.8% | $61.2B-0.8% | $61.7B+1.8% | $60.6B-5.5% | $64.1B+9.6% | $58.5B-2.6% | $60.0B |
| Retained Earnings | $54.4B+29.1% | $42.1B+5.1% | $40.1B+14.5% | $35.0B-2.9% | $36.0B-3.4% | $37.3B+13.1% | $33.0B+10.5% | $29.9B+4.6% | $28.5B+23.9% | $23.0B-6.0% | $24.5B |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
BBVXF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.6Bn/m | -$18.8Bn/m | -$797.6M-103.1% | $25.4Bn/m | -$1.4B-102.9% | $48.1Bn/m | -$12.0B-177.7% | $15.4B+643.5% | $2.1B-70.4% | $7.0B-72.1% | $25.1B |
| Depreciation & Amortization | $1.8B+12.5% | $1.6B+2.2% | $1.6B+9.2% | $1.4B+1.7% | $1.4B-11.3% | $1.6B+1.2% | $1.6B+31.4% | $1.2B-29.0% | $1.7B+10.8% | $1.5B+8.9% | $1.4B |
| Capital Expenditures | $970.6M-21.5% | $1.2B-1.0% | $1.2B-35.6% | $1.9B+332.5% | $448.2M-42.0% | $772.9M-19.2% | $956.5M | N/A | N/A | N/A | N/A |
| Free Cash Flow | $16.6Bn/m | -$20.1Bn/m | -$2.0B-108.7% | $23.4Bn/m | -$1.9B-103.9% | $47.4Bn/m | -$12.9B | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | -$4.2Bn/m | -$1.8Bn/m | -$45.3M-141.6% | $108.9M-98.7% | $8.6B+146.8% | $3.5Bn/m | -$590.9Mn/m | -$4.8B |
| Financing Cash Flow | N/A | N/A | N/A | -$8.1Bn/m | -$4.9Bn/m | -$2.5Bn/m | -$3.0Bn/m | -$5.8Bn/m | -$117.8Mn/m | -$1.2B-951.6% | $137.9M |
| Dividends Paid | $4.9B+21.6% | $4.1B+30.4% | $3.1B+32.9% | $2.3B+123.0% | $1.0B-19.5% | $1.3B-46.0% | $2.4B-0.1% | $2.4B+18.2% | $2.0B+21.0% | $1.7B+76.8% | $954.5M |
| Share Buybacks | $2.3B+48.0% | $1.6B-34.0% | $2.4B-24.5% | $3.2B+174.3% | $1.2B+17.2% | $987.0M-19.2% | $1.2B-36.6% | $1.9B-4.2% | $2.0B-4.8% | $2.1B-40.6% | $3.6B |
Not reported in any period shown, so not listed: Stock-Based Compensation.
BBVXF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 100.0% |
| Operating Margin | 43.7%+0.5pp | 43.3%+1.2pp | 42.1%+0.2pp | 41.9%+6.4pp | 35.5%+10.0pp | 25.6%-7.9pp | 33.5%+1.0pp | 32.5%+3.9pp | 28.6%+0.7pp | 27.9%+1.1pp | 26.8% |
| Net Margin | 28.5%+0.1pp | 28.3%+1.2pp | 27.1%+1.4pp | 25.7%+3.6pp | 22.1%+15.6pp | 6.5%-9.9pp | 16.3%-9.5pp | 25.8%+11.9pp | 13.9%-0.2pp | 14.1%+2.8pp | 11.3% |
| Return on Equity | 17.0%+0.3pp | 16.8%+2.2pp | 14.5%+1.9pp | 12.6%+3.0pp | 9.6%+6.9pp | 2.6%-3.8pp | 6.4%-3.8pp | 10.2%+3.6pp | 6.6%+0.3pp | 6.3%+1.5pp | 4.8% |
| Return on Assets | 1.2%-0.1pp | 1.3%+0.3pp | 1.0%+0.1pp | 0.9%+0.2pp | 0.7%+0.5pp | 0.2%-0.3pp | 0.5%-0.3pp | 0.8%+0.3pp | 0.5%0.0pp | 0.5%+0.1pp | 0.4% |
| Liabilities-to-Equity | 12.91+1.0x | 11.87-1.2x | 13.03-0.1x | 13.10+0.5x | 12.60-1.1x | 13.67+2.0x | 11.66-0.1x | 11.78-0.2x | 11.94-0.3x | 12.20-0.4x | 12.56 |
| Asset Turnover | 0.040.0x | 0.050.0x | 0.040.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.040.0x | 0.030.0x | 0.03 |
| FCF Margin | 38.3%+92.9pp | -54.6%-48.4pp | -6.3%-94.8pp | 88.5%+96.3pp | -7.8% | 192.0% | -53.5% | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Current Ratio, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Banco Bilbao V/Argntna SA BBVXF | FY2025 | $43.3B | $12.3B | 28.5% | $140.3B | — |
| Banco Santndr New BCDRF | FY2025 | $68.9B | $16.5B | 24.0% | $171.9B | — |
| ING Groep NV INGVF | FY2025 | $30.1B | $9.8B | 32.4% | $92.6B | — |
| Westpac BKG Corp WBKCY | FY2025 | $38.4B | $4.6B | 11.9% | $90.8B | — |
| Barclays PLC BCLYF | FY2025 | $39.2B | $9.6B | 24.6% | $76.7B | — |
Where Banco Bilbao V/Argntna SA Ranks
Frequently Asked Questions
Banco Bilbao V/Argntna SA (BBVXF) reported $43.3B in total revenue for fiscal year 2025. This represents a 18.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Banco Bilbao V/Argntna SA (BBVXF) revenue grew by 18.0% year-over-year, from $36.7B to $43.3B in fiscal year 2025.
Yes, Banco Bilbao V/Argntna SA (BBVXF) reported a net income of $12.3B in fiscal year 2025, with a net profit margin of 28.5%.
Banco Bilbao V/Argntna SA (BBVXF) had EBITDA of $20.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Banco Bilbao V/Argntna SA (BBVXF) had an operating margin of 43.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Banco Bilbao V/Argntna SA (BBVXF) had a net profit margin of 28.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Banco Bilbao V/Argntna SA (BBVXF) has a return on equity of 17.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Banco Bilbao V/Argntna SA (BBVXF) generated $16.6B in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Banco Bilbao V/Argntna SA (BBVXF) generated $17.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Banco Bilbao V/Argntna SA (BBVXF) had $1.0T in total assets as of fiscal year 2025, including both current and long-term assets.
Banco Bilbao V/Argntna SA (BBVXF) invested $970.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Banco Bilbao V/Argntna SA (BBVXF) had a liabilities-to-equity ratio of 12.91 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
Banco Bilbao V/Argntna SA (BBVXF) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Banco Bilbao V/Argntna SA (BBVXF) trades at 11.4x earnings, its market capitalization divided by $12.3B net income, FY2025. The market capitalization is $140.3B as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Banco Bilbao V/Argntna SA (BBVXF) trades at 3.2x sales, its market capitalization divided by $43.3B revenue, FY2025. The market capitalization is $140.3B as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Banco Bilbao V/Argntna SA (BBVXF) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Banco Bilbao V/Argntna SA (BBVXF) has an interest coverage ratio of 0.50x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.